Summary of change from baseline in ACT total score and number of prescribed salbutamol inhalers
| Usual care (n=1155) | FF/VI (n=1081) | |
| Change from baseline in ACT total score | ||
| Week 12 | ||
| n | 1104 | 1021 |
| LS mean change (SE) | 1.89 (0.115) | 3.40 (0.120) |
| Difference* (95% CI) | 1.51 (1.19 to 1.83), p<0.001 | |
| Week 24 | ||
| n | 1063 | 988 |
| LS mean change (SE) | 1.75 (0.125) | 3.24 (0.130) |
| Difference* (95% CI) | 1.49 (1.14 to 1.84), p<0.001 | |
| Week 40 | ||
| n | 1048 | 957 |
| LS mean change (SE) | 1.67 (0.127) | 3.13 (0.134) |
| Difference* (95% CI) | 1.45 (1.10 to 1.81), p<0.001 | |
| Week 52 | ||
| n | 1046 | 962 |
| LS mean change (SE) | 1.60 (0.124) | 3.05 (0.130) |
| Difference* (95% CI) | 1.45 (1.10 to 1.80), p<0.001 | |
| Number of salbutamol inhalers prescribed during the study | ||
| n (patients) | 1154 | 1076 |
| LS mean (SE) | 8.0 (0.14) | 7.2 (0.14) |
| Difference* (95% CI) | −0.8 (−1.2 to −0.5), p<0.001 | |
*FF/VI vs usual care.
ACT, Asthma Control Test; FF/VI, fluticasone furoate/vilanterol; LS, least squares.